Prague, Czechia

Alena Prokopova

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Sanofi. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alena Prokopova: Innovator in Pharmaceutical Composition

Introduction

Alena Prokopova is a notable inventor based in Prague, Czech Republic. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on drug compositions. Her expertise and dedication have led to the development of a unique pharmaceutical composition that combines two active ingredients.

Latest Patents

Alena Prokopova holds 1 patent for her invention titled "Pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof." This invention relates to a pharmaceutical composition that includes rosuvastatin and ezetimibe, along with a method for preparing this composition. The active ingredients are carefully formulated in a specific weight ratio, enhancing their therapeutic efficacy.

Career Highlights

Throughout her career, Alena has worked with prominent companies in the pharmaceutical industry, including Sanofi and Zentiva. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in drug development.

Collaborations

Alena Prokopova has collaborated with talented professionals in her field, including Ondrej Dammer and Jaroslava Svobodova. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alena Prokopova's contributions to pharmaceutical innovation exemplify her commitment to improving healthcare through her inventions. Her work continues to impact the industry positively, showcasing the importance of creativity and collaboration in scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…